European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Policy Document Development Strategy – Clinical Practice Guidelines, Position Statements and Technological Reviews

Christian Jenssen; Odd Helge Gilja; Andreas L. Serra; Fabio Piscaglia; Christoph F. Dietrich; Lynne Rudd; Paul S. Sidhu

doi:10.1055/a-0770-3965

Ultrasound International Open, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Ultrasound Int Open 2019; 05(01): E2-E10
DOI: 10.1055/a-0770-3965

Quality Assurance

European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Policy Document Development Strategy – Clinical Practice Guidelines, Position Statements and Technological Reviews

Christian Jenssen

¹Krankenhaus Märkisch Oderland Strausberg/ Wriezen, Klinik für Innere Medizin, Wriezen, Germany

,

Odd Helge Gilja

²National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway

,

Andreas L. Serra

³Klinik Hirslanden, Department of Internal Medicine and Nephrology, Zurich, Switzerland

,

Fabio Piscaglia

⁴Div. Internal Medicine, Dept of Medical and Surgical Sciences, Bologna, Italy

,

Christoph F. Dietrich

⁵Caritas-Krankenhaus, Medizinische Klinik 2, Bad Mergentheim, Germany

,

Lynne Rudd

⁶European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) , General Secretary, London, United Kingdom of Great Britain and Northern Ireland

,

Paul S. Sidhu

⁷King’s College London, Radiology, London, United Kingdom of Great Britain and Northern Ireland

› Institutsangaben

Abstract

This document summarizes principles and methodology to guide the creation of Clinical Practice Guidelines, Position Statements und Technological Reviews of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). The purpose of EFSUMB Clinical Practice Guidelines is to provide physicians and sonographers performing or requesting diagnostic and interventional ultrasound examinations with evidence-based recommendations. Position Statements summarize EFSUMB opinions on important current issues in clinical applications, education and training of ultrasound techniques or health care policy related to ultrasound-based imaging and ultrasound-guided interventions. The third type of EFSUMB policy document is the Technological Review, which describes ultrasound techniques and technologies for physicians, medical technicians, engineers and physicists developing ultrasound technology. The whole process of development of EFSUMB policy documents is explained beginning with the decision regarding topics, selection of authors, funding, and planning of the developmental process. Further steps described in this document are the review of the evidence, creation of recommendations, statements and comments, grading of level of evidence and strength of recommendations, and consensus process. Finally, rules for the creation, review, approval, publication and update of EFSUMB policy documents are described.

Key words

evidence - ultrasound - clinical practice guidelines - technological reviews - position statements

Volltext

Referenzen

References
1 Dietrich CF, Rudd L, Saftiou A, Gilja OH. The EFSUMB website, a great source for ultrasound information and education. Med Ultrason 2017; 19: 102-110
2 Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L. et al. Guidelines for the use of contrast agents in ultrasound. January 2004 Ultraschall Med 2004; 25: 249-256
3 Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 2008; 29: 28-44
4 Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, Albrecht T. et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 33: 33-59
5 Dietrich CF, Averkiou MA, Correas JM, Lassau N, Leen E, Piscaglia F. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med 2012; 33: 344-351
6 Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, Piscaglia F. et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
7 Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, Piscaglia F. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34: 11-29
8 Sidhu PS, Piscaglia F, Bartels E, Bertolotto M, Callida F, Cantisani V, Clevert DA et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast enhanced ultrasound (CEUS) in non-hepatic applications: Update 2017. Ultraschall Med 2018; 39: accepted for publication
9 Bamber J, Cosgrove D, Dietrich CF, Fromageau J, Bojunga J, Calliada F, Cantisani V. et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 2013; 34: 169-184
10 Cosgrove D, Piscaglia F, Bamber J, Bojunga J, Correas JM, Gilja OH, Klauser AS. et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 2013; 34: 238-253
11 Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, Cosgrove D. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med 2017; 38: e16-e47
12 Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, Cosgrove D. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall Med 2017; 38: 377-394
13 Dietrich CF, Lorentzen T, Sidhu PS, Jenssen C, Gilja OH, Piscaglia F. Efsumb An Introduction to the EFSUMB Guidelines on Interventional Ultrasound (INVUS). Ultraschall Med 2015; 36: 460-463
14 Lorentzen T, Nolsoe CP, Ewertsen C, Nielsen MB, Leen E, Havre RF, Gritzmann N. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (long Version). Ultraschall Med 2015; 36: E1-E14
15 Lorentzen T, Nolsoe CP, Ewertsen C, Nielsen MB, Leen E, Havre RF, Gritzmann N. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (Short Version). Ultraschall Med 2015; 36: 464-472
16 Sidhu PS, Brabrand K, Cantisani V, Correas JM, Cui XW, D'Onofrio M, Essig M. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Long Version). Ultraschall Med 2015; 36: E15-E35
17 Sidhu PS, Brabrand K, Cantisani V, Correas JM, Cui XW, D'Onofrio M, Essig M. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Short Version). Ultraschall Med 2015; 36: 566-580
18 Dietrich CF, Lorentzen T, Appelbaum L, Buscarini E, Cantisani V, Correas JM, Cui XW. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Long Version). Ultraschall Med 2016; 37: E1-E32
19 Dietrich CF, Lorentzen T, Appelbaum L, Buscarini E, Cantisani V, Correas JM, Cui XW. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Short Version). Ultraschall Med 2016; 37: 27-45
20 Jenssen C, Hocke M, Fusaroli P, Gilja OH, Buscarini E, Havre RF, Ignee A. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV - EUS-guided Interventions: General aspects and EUS-guided sampling (Long Version). Ultraschall Med 2016; 37: E33-E76
21 Jenssen C, Hocke M, Fusaroli P, Gilja OH, Buscarini E, Havre RF, Ignee A. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV - EUS-guided interventions: General Aspects and EUS-guided Sampling (Short Version). Ultraschall Med 2016; 37: 157-169
22 Fusaroli P, Jenssen C, Hocke M, Burmester E, Buscarini E, Havre RF, Ignee A. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V. Ultraschall Med 2016; 37: 77-99
23 Fusaroli P, Jenssen C, Hocke M, Burmester E, Buscarini E, Havre RF, Ignee A. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V - EUS-Guided Therapeutic Interventions (short version). Ultraschall Med 2016; 37: 412-420
24 Jenssen C, Brkljacic B, Hocke M, Ignee A, Piscaglia F, Radzina M, Sidhu PS. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part VI - Ultrasound-Guided Vascular Interventions. Ultraschall Med 2016; 37: 473-476
25 Nylund K, Maconi G, Hollerweger A, Ripolles T, Pallotta N, Higginson A, Serra C. et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med 2017; 38: e1-e15
26 Nylund K, Maconi G, Hollerweger A, Ripolles T, Pallotta N, Higginson A, Serra C. et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med 2017; 38: 273-284
27 Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, Marteau T. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998; 2: i-iv 1–88
28 Black N, Murphy M, Lamping D, McKee M, Sanderson C, Askham J, Marteau T. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy 1999; 4: 236-248
29 Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A. et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004; 4: 38
30 Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH. et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490
31 Hutchings A, Raine R, Sanderson C, Black N. A comparison of formal consensus methods used for developing clinical guidelines. J Health Serv Res Policy 2006; 11: 218-224
32 Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
33 Phillips B, Ball C, Sackett D, Badenoch D, Straus S. B. H Dawes M. et al. Oxford Centre for Evidence-based Medicine – Levels of Evidence 1. In. Oxford: Oxford Centre for Evidence-Based Medicine; 2009
34 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B. et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 2010; 63: 1308-1311
35 Graham R, Mancher M. D. MW S. G Steinberg E. (Editors) Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011
36 Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I. et al. The Oxford Levels of Evidence 2. In. Oxford: Oxford Centre for Evidence-Based Medicine; 2011
37 Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I. et al Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). In. Oxford: Oxford Centre for Evidence-Based Medicine; 2011
38 Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum 2011; 41: 95-105
39 Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, van der Wees P. Board of Trustees of the Guidelines International N. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 2012; 156: 525-531
40 Schunemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, Ventresca M. et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 2014; 186: E123-E142
41 James D, Warren-Forward H. Research methods for formal consensus development. Nurse Res 2015; 22: 35-40
42 Frieden TR. Evidence for Health Decision Making - Beyond Randomized, Controlled Trials. N Engl J Med 2017; 377: 465-475
43 Lenzer J, Hoffman JR, Furberg CD, Ioannidis JP. Guideline Panel Review Working G. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ 2013; 347: f5535
44 Schunemann HJ, Al-Ansary LA, Forland F, Kersten S, Komulainen J, Kopp IB, Macbeth F. et al. Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. Ann Intern Med 2015; 163: 548-553
45 Semlitsch T, Blank WA, Kopp IB, Siering U, Siebenhofer A. Evaluating Guidelines: A Review of Key Quality Criteria. Dtsch Arztebl Int 2015; 112: 471-478
46 Shaughnessy AF, Cosgrove L, Lexchin JR. The Need to Systematically Evaluate Clinical Practice Guidelines. J Am Board Fam Med 2016; 29: 644-648
47 Neumann I, Santesso N, Akl EA, Rind DM, Vandvik PO, Alonso-Coello P, Agoritsas T. et al. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J Clin Epidemiol 2016; 72: 45-55
48 Shaneyfelt T. Pyramids are guides not rules: the evolution of the evidence pyramid. Evid Based Med 2016; 21: 121-122
49 Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schunemann HJ. et al. Going from evidence to recommendations. BMJ 2008; 336: 1049-1051
50 Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ, Group GW. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008; 336: 995-998
51 Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I. et al. The 2011 Oxford CEBM Levels of Evidence (Introductory Document). In. Oxford: Oxford Centre for Evidence-Based Medicine; 2011
52 Welch VA, Akl EA, Guyatt G, Pottie K, Eslava-Schmalbach J, Ansari MT, de Beer H. et al. GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale. J Clin Epidemiol 2017; 90: 59-67
53 Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams Jr. JW. et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336: 1106-1110
54 Brozek JL, Akl EA, Compalati E, Kreis J, Terracciano L, Fiocchi A, Ueffing E. et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy 2011; 66: 588-595
55 Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M. GRADE guidelines: 14. et al. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66: 719-725
56 Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, Rind D. GRADE guidelines: 15. et al. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013; 66: 726-735
57 Schunemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, Brignardello-Petersen R. et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol 2017; 81: 101-110
58 Akl EA, Meerpohl JJ, Elliott J, Kahale LA, Schunemann HJ. Living Systematic Review N. Living systematic reviews: 4. Living guideline recommendations. J Clin Epidemiol 2017; 91: 47-53